Title: Recent advancements in drug treatment of obesity.
Journal: Clinical medicine (London, England) 20121001
Title: Non-systemic drugs: a critical review.
Journal: Current pharmaceutical design 20120401
Title: [The pharmacological treatment of obesity: past, present and future].
Journal: Orvosi hetilap 20120311
Title: Anti-Obesity Drugs: A Review about Their Effects and Safety.
Journal: Diabetes & metabolism journal 20120201
Title: Current and future drug targets in weight management.
Journal: Pharmaceutical research 20110801
Title: Pharmacological treatment of obesity in children and adolescents: present and future.
Journal: Journal of obesity 20110101
Title: Management of diabetes across the course of disease: minimizing obesity-associated complications.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20110101
Title: [Recent progress and novel perspectives on obesity pharmacotherapy].
Journal: Arquivos brasileiros de endocrinologia e metabologia 20100801
Title: Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical).
Journal: Obesity (Silver Spring, Md.) 20100101
Title: [Drug treatment of obesity--current situation and perspectives].
Journal: Casopis lekaru ceskych 20100101
Title: Tackling obesity: new therapeutic agents for assisted weight loss.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20100101
Title: The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20100101
Title: Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers.
Journal: British journal of clinical pharmacology 20090301
Title: Cetilistat (ATL-962), a novel pancreatic lipase inhibitor, ameliorates body weight gain and improves lipid profiles in rats.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20080801
Title: Cetilistat, a new lipase inhibitor for the treatment of obesity.
Journal: Current opinion in investigational drugs (London, England : 2000) 20080401
Title: Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.
Journal: International journal of obesity (2005) 20070301
Title: Obesity drugs in clinical development.
Journal: Current opinion in investigational drugs (London, England : 2000) 20060401
Title: Yamada Y, et al. Cetilistat (ATL-962), a novel pancreatic lipase inhibitor, ameliorates body weight gain and improves lipid profiles in rats. Horm Metab Res. 2008 Aug;40(8):539-43.
